BEACHWOOD, Ohio, March 3 /PRNewswire/ --

Aleris International, Inc. will issue its fourth quarter and full year 2007 results before the market opens on Tuesday, March 18, 2008. That same day at 9:00 a.m. Eastern time Steven J. Demetriou, Chairman and Chief Executive Officer, and Sean M. Stack, Executive Vice President and Chief Financial Officer, will host a conference call to discuss results.

The live conference call can be accessed by dialing 800-901-5217 or +1-617-786-2964 and referencing passcode 52887147 at least 10 minutes prior to the presentation, which will begin promptly at 9:00 a.m. Eastern time. In addition, the conference call will be broadcast live over the Internet at www.aleris.com.

GRIESHEIM, Germany, March 3 /PRNewswire/ --

- Company Will Showcase its HughesNet(R) Enterprise VPN Solutions

Hughes Network Systems, LLC (HUGHES) announced today that its European operating unit is showcasing its comprehensive portfolio of HughesNet broadband solutions and managed services on March 4 - 9, 2008 at CeBIT 2008, booth E 33, Hall 13. Available continent-wide, the suite of HughesNet Managed Network Services means enterprises of all sizes can enjoy the benefits of high performance broadband connectivity at any number of locations, and including VPN solutions for optimized networks, high-availability networks and access continuity services.

HOLMDEL, New Jersey, March 3 /PRNewswire/ --

- Leading Russian Wireless Service Provider Deploys OnePlan Network Resource Planning to Reduce Backhaul Expenses and Strengthen Network for Next Generation Services

Call it Wireless 2.0. Seeing their voice service revenues plateau, wireless service providers are bringing a new generation of data services to market in the hopes of invigorating subscriber revenue growth (ARPU). Launching those new services, however, requires providers to strike a perfect balance between adding sufficient backhaul support to ensure a superior quality of experience (QoE) for users and minimizing backhaul expenses to grow net revenue and not just ARPU.

HANNOVER, Germany, March 3 /PRNewswire/ --

- Steve Ballmer discusses environmental sustainability efforts from Microsoft and general availability of enterprise products.

ANN ARBOR, Michigan, March 3 /PRNewswire/ --

Terumo Heart, Inc. announced today that they have received conditional approval from the Food and Drug Administration (FDA) to begin enrollment in the US Pivotal Trial of the DuraHeart (TM) LVAS for a Bridge-to-Transplant (BTT) indication.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070227/CLTU043LOGO ) (Photo: http://www.newscom.com/cgi-bin/prnh/20080303/CLM012 )

BASINGSTOKE, England and PHILADELPHIA, Pennysylvania, March 3 /PRNewswire/ -- Shire plc (LSE: SHP)(NASDAQ: SHPGY), the global specialty biopharmaceutical company, notes that Renovo Group plc, (LSE: RNVO) ("Renovo") has today announced the results of Renovo's latest Phase 2 studies of JUVISTA(R) (human recombinant TGFbeta3) in scar revision surgery (RN1001-319-1009) and in breast augmentation (RN1001-319-1010).

Renovo’s press release can be found on http://www.renovo.com.

The two trials announced by Renovo are part of a broad global Phase 2 clinical program to assess the safety, efficacy, dose and dose frequency of JUVISTA in a variety of surgical procedures.